March 29, 2022 Quanterix Receives Funding from the Alzheimer’s Drug Discovery Foundation to Accelerate Alzheimer’s Disease Diagnostic Plasma Test Development read more
February 28, 2022 Quanterix Corporation Garners Five Best Places to Work Awards from Comparably read more
February 28, 2022 Quanterix Announces New Agreements with Lilly to Advance Alzheimer’s Disease Diagnosis and Treatment read more
February 28, 2022 Quanterix Corporation Releases Operating Results for Fourth Quarter and Full Year 2021 read more
November 16, 2021 Quanterix’ Simoa® Technology Powers Advances in Alzheimer’s Disease Research Presented at 2021 Clinical Trials on Alzheimer’s Disease (CTAD) Conference read more
November 4, 2021 Quanterix Corporation Releases Operating Results for Third Quarter of 2021 read more
October 11, 2021 Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based pTau-181 Assay for Alzheimer’s Disease read more
September 20, 2021 Quanterix Hosts Webinar with Leading Pathologist from Emory Medical Laboratories read more